Document Detail

Heart rate variability is decreased in chronic kidney disease but may improve with hemoglobin normalization.
MedLine Citation:
PMID:  18264936     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Cardiac autonomic function can be measured by heart rate variability (HRV). Dialysis patients have an abnormally low HRV and are at increased risk for sudden death. A reduction in HRV is associated with anemia. HRV was therefore measured in patients with chronic kidney disease (CKD) after hemoglobin normalization. METHODS: Sixteen nondiabetic patients with CKD stage 4 (glomerular filtration rate 23.7 +/- 13.9 ml/min) and renal anemia received epoetin aiming at a hemoglobin level of 135-150 g/L. HRV was measured by 24-hour Holter electrocardiogram at baseline and after hemoglobin normalization and in a reference group consisting of 16 volunteers without impairment of renal function. RESULTS: Hemoglobin level increased from 100.7 +/- 12.6 g/L to 142.4 +/- 7.2 g/L during the study. At baseline, HRV measured in the time domain as the standard deviation of all normal RR intervals in the entire 24-hour electrocardiogram (SDNN) was 116.3 +/- 39.2 ms compared with 147.5 +/- 27.2 ms in the reference group (p<0.05). The frequency domain measures low-frequency power and total power were 367.7 +/- 350.2 ms2 and 1,368.9 +/- 957.4 ms2 compared with 717.3 +/- 484.5 ms2 and 2,228.3 +/- 1142.4 ms2 (p<0.05) in the reference group. After hemoglobin normalization there was an increase in low-frequency power to 498.3 +/- 432.7 ms2 (p<0.05) and in total power to 1,731.0 +/- 1,069.4 ms2 (p<0.05) while SDNN remained at 120.9 +/- 33.8 ms (p=ns). CONCLUSIONS: CKD patients not yet on dialysis had a reduced HRV, indicating impaired autonomic function, compared with a reference group without impaired renal function. Hemoglobin normalization improved but did not fully normalize HRV. The clinical significance of this deserves further investigation.
Hans Furuland; Torbjörn Linde; Anders Englund; Björn Wikström
Related Documents :
12837136 - Total and corrected antioxidant capacity in hemodialyzed patients.
10069646 - Response of hyperhomocysteinemia to folic acid supplementation in patients with end-sta...
15185776 - Exercise capacity in pediatric patients with end-stage renal disease.
12371716 - Continuous renal replacement therapies.
2679046 - Gastric varices: profile, classification, and management.
2251956 - Abnormalities of central motor conduction in asymptomatic hiv-positive patients. signif...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of nephrology     Volume:  21     ISSN:  1121-8428     ISO Abbreviation:  J. Nephrol.     Publication Date:    2008 Jan-Feb
Date Detail:
Created Date:  2008-02-11     Completed Date:  2008-05-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9012268     Medline TA:  J Nephrol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  45-52     Citation Subset:  IM    
Department of Medical Sciences, University Hospital, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / physiopathology
Blood Pressure
Chronic Disease
Heart Rate*
Hemoglobins / analysis*
Kidney Diseases / blood,  physiopathology*
Middle Aged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic k...
Next Document:  TGF-beta1 and CTGF mRNAs are correlated with urinary protein level in IgA nephropathy.